1Luft R, Ikkos D, Palmieri G, et al. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest,1962 ,41:1776～1804.
2Wallace DC,Singh G,Lott MT,et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988,242(4884):1427～1430.
3Campos Y,Huertas R,Bautista J,et al. Muscle carnitine deficiency and lipid storage myopathy in pathients with mitochondrial myopathy. Muscle &Nerve,1993,16:778～781.
4Dalakas MC,Leon-Monzon ME,Bernardini Isa, et al. Zidovodine induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Ann Neurol,1994,35:482～487.
7Attardi G,Yone M,Chomym A. Complementation and segregation behavior of disease-causing mitochondrial DNA mutations in cellular model systems.Biochim Biophys Acta,1995,1271(1):241～248.
8Fosslien E. Mitochondrial medicine-molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci,2001,31(1):25～67.
9Farrants GW,Hovmoller S,Stadhouders AM. Two type of mitochondrial crystals in diseased human skeletal muscle fibers[J].Muscle Nerve,1988,11(1):45～55.
二级参考文献12
1[1]Campos Y. Huertas R,Bautista J, et al. Muscle carnitine deficiency and lipid storage myopathy in pathients with mitochondrial myopathy. Muscle & Nerve, 1993,16∶778～781.
2[2]Garavaglia B, Uziel G, Dworzak F, et al. Primary carnitine deficiency. Heterozygote and intrafamilial phenotypic variation. Neuroloy, 1991,41∶1691～1693.
3[3]Dalakas MC, Leon-Monzon ME, Bernardini Isa, et al. Zidovudineinduced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Ann Neurol, 1994,35∶482～487.
4[4]Turnbull DM, Shepherd IM, Ashworth B, et al. Lipid storage myopathy associated with low acyl-CoA dehydrogenase activites. Brain, 1988,111∶815～828.
5[5]Patten BM, Shabot JM, Alperin J, et al. Hepatitis-associated lipid storage myopathy. Ann Intern Med, 1977,87∶471～421.
6[6]Arenas J, Gonzalez-Crespo MR, Campos Y, et al. Abnormal carnitine ditribution in the muscles of patients with idiopathic inflammatory myopathy. Arthritis & Rheumatism, 1996,39∶1869～1874.
7[7]Antozzi C, Garavaglia B, Mora M, et al. Late-onset riboflavin-responsive myopathy with combined multiple acyl conenzyme A dehydrogenase and respiratory chain deficiency. Neurology, 1994,44∶2153～2158.
8[8]Araki E, Kobayashi T, Kohtake N, et al. Ariboflavin-responsive lipid storage myopathy due to multiple acyl-CoA dehydrogenase deficiency: an adult case. Journal of the neurological sciences, 1994,126∶202～205.
9[9]DiDonato S, Gellera C, Peluchetti D, et al. Normalization of short-chain acylcoenzyme A dehydrogenase after riboflavin treatment in girl with multiple acycoenzyme A dehydrogenase-deficient myopathy. Ann Neurol, 1989,25∶479～484.
10[10]Vergani L, Barile M, Angelini C, et al. Riboflavin therapy: biochemical heterogeneity in tow adult lipid storage myopathies. Brain, 1999,122∶2401～2411.
